Article

Abbate, V, Kicman, AT, Evans-Brown, M, McVeigh, J, Cowan, DA, Wilson, C, Coles, SJ and Walker, CJ (2015) Anabolic steroids detected in bodybuilding dietary supplements - a significant risk to public health. DRUG TESTING AND ANALYSIS, 7 (7). pp. 609-618. ISSN 1942-7603

Hope, VD, McVeigh, J, Marongiu, A, Evans-Brown, M, Smith, J, Kimergård, A, Croxford, S, Beynon, CM, Parry, JV, Bellis, MA and Ncube, F (2013) Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open, 3 (9). ISSN 2044-6055

Monograph

De Morais, J, Brandt, SD, Jorge, R, Christie, R, Gallegos, A, Sedefov, R and Evans-Brown, M (2020) EMCDDA technical report on the new psychoactive substance methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

De Morais, J, Brandt, SD, Jorge, R, Christie, R, Gallegos, A, Sedefov, R and Evans-Brown, M (2020) EMCDDA technical report on the new psychoactive substance methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, de Morais, J, Sola, S and Sedefov, R (2017) Technical report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA). Annex 1 to the Risk Assessment Report on 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3- carboxamide (CUMYL-4CN-BINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, de Morais, J, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (ADB-CHMINACA). Annex 1 to the Risk Assessment Report on N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Gallegos, A and Sedefov, R (2017) Technical report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Annex 1 to the Risk Assessment Report on N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.

Brandt, SD, Elliott, S, Evans-Brown, M, Valur Danielsson, H, Almeida, A, Jorge, R, Christie, R, Sola, S, Gallegos, A and Sedefov, R (2017) Technical report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide (tetrahydrofuranylfentanyl; THF-F). Annex 1 to the Risk Assessment Report on N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2- carboxamide (tetrahydrofuranylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon.

Brandt, SD, Elliott, S, Valur Danielsson, H, Almeida, A, Gallegos, A, Jorge, R, Christie, R, Evans-Brown, M and Sedefov, R (2017) Furanylfentanyl. ANNEX 1. Technical report on N-phenyl-N- [1-(2-phenylethyl)piperidin-4-yl]furan- 2-carboxamide (furanylfentanyl). Technical Report. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg.